Options Flow Flags Semis, Biotech Bets

Negative options bets are clustering in semiconductors this week. Micron leads the large-cap put flow, with NVIDIA and Advanced Micro Devices also drawing heavy bearish order volume over the past seven days. The three names account for some of the biggest negative options bets among US mid-and-large caps screened by ORTEX. Chip stocks have posted mixed price action year-to-date, with Micron up 217% and AMD up 148%, leaving elevated strike prices as natural put targets ahead of upcoming earnings.

Meta Platforms sits at RSI 33.65 and is down 4.5% year-to-date. Its options flow shows negative bets in the top tier of the large-cap universe. The stock reports Q3 results imminently. Traders appear to be positioning for a downside move rather than a recovery.

Moderna carries a short score of 52.3 and a short interest of 8.9% of free float. ORTEX's Index Rebalance Radar puts the probability of a MSCI World addition at 88%, which would require $4.4B of tracker buying. That index event hangs over any bearish options positioning. The announcement is due 11 November.

Coca-Cola sits at the other end of the sentiment spectrum. Its YTD gain is 32.6% and RSI stands at 59.7. The company flagged accelerating cost pressures today. That news may shift options sentiment in coming sessions. Immuneering Corporation carries short interest of 33% of free float. Drug trials data shows trial completion date slippage running 1.8 standard deviations below its own history as of 9 October, per ORTEX's drug trials dataset, pointing to accelerating timelines.